摘要
ACS的临床表现可为,胸闷、胸痛伴气短、出汗,心衰,心律失常以及猝死。并伴有冠脉血管痉挛,管腔明显狭窄,甚至完全被堵塞,从而出现心肌缺血缺氧,严重时心肌坏死[1]。近年来研究发现:其进展过程中伴随的生化标记物超敏C反应蛋白、D-二聚体的改变可帮助临床医师及早识别病人的临床症状并为心电图改变不典型病人提供积极个体化的治疗方案,同时对评估其病情及预后、起到极大的作用。现将对急性冠脉综合征中(ACS)超敏C反应蛋白联合D-二聚体检测的研究进展进行综述。
Acute coronary symdrome（ ACS） is caused by cononary atherosclerosis rupture,platelet adhesion,platelet aggregation,platelet release,through which the coagulation system is activated leading to the blood clot. ACS is usually accompanied by vasospasm,stenosis of arterioles,even worse,myocardial ischemia from completely blocking and myocardial necrosis. The research tells us that through biochemical marker- hyper sensitive C reactive protein and D- dimer（ increase）,phisician can recognize some symdromes in early time,help ACS patients with atypical ECG changes and give them individual treatment; in addition,the two marker also play an important role in evaluating severity and prognosis. This review will present development in application of hyper- sensitive C reative protein and D- dimer in ACS.
出处
《内蒙古医科大学学报》
2015年第2期190-194,共5页
Journal of Inner Mongolia Medical University
基金
内蒙古教育厅高等学校科学研究项目(NJZY11119)
作者简介
杜丽萍（1974-），女，内蒙古医科大学2012级在读硕士研究生。
通讯作者：扈瑞平，教授，博士，E-mail：huruiping2007@163．com.内蒙古医科大学，010059
